CELYAD
Celyad is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T NKR-2, C-Cure. The firm has CYAD-01, CYAD-02, CYAD-03 programs in pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Immuno-oncology operating segments.
CELYAD
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2007-01-01
Address:
Mont-saint-guibert, Brabant Wallon, Belgium
Country:
Belgium
Website Url:
http://www.celyad.com
Total Employee:
51+
Status:
Active
Contact:
+32(0) 10 39 41 00
Email Addresses:
[email protected]
Total Funding:
146.1 M USD
Technology used in webpage:
Person Schema Gravatar Profiles Lorem Ipsum Comcast 3 To 9 CcTLD Redirects
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Gamida Cell
Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Imara
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Summit Therapeutics
Summit Therapeutics is a clinical-stage drug discovery and development company.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-06-30 | Biological Manufacturing Services | Biological Manufacturing Services acquired by Celyad | N/A |
| 2015-01-06 | OnCyte | OnCyte acquired by Celyad | N/A |
| 2014-11-05 | CorQuest Medical | CorQuest Medical acquired by Celyad | N/A |
Investors List
Fortress Investment Group
Fortress Investment Group investment in Post-IPO Equity - Celyad
Hunza Ventures
Hunza Ventures investment in Venture Round - Celyad
Grifols
Grifols investment in Venture Round - Celyad
Life Sciences Research Partners V.Z.W.
Life Sciences Research Partners V.Z.W. investment in Series B - Celyad
Hunza Ventures
Hunza Ventures investment in Series B - Celyad
Grifols
Grifols investment in Series B - Celyad
S.R.I.W.
S.R.I.W. investment in Series A - Celyad
Official Site Inspections
http://www.celyad.com Semrush global rank: 3.57 M Semrush visits lastest month: 4.05 K
- Host name: 109.230.214.35.bc.googleusercontent.com
- IP address: 35.214.230.109
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
